-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SHZrw+8q6GSjQwls3AWZLPHBokAHTAEPse5X7sX0dTCB+/yzt5E0ZYAGiRDOvj9Q CrO+0wKPkg35mfh4u3Zh7A== 0000950117-03-001430.txt : 20030414 0000950117-03-001430.hdr.sgml : 20030414 20030414162214 ACCESSION NUMBER: 0000950117-03-001430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020102 FILED AS OF DATE: 20030414 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02516 FILM NUMBER: 03648769 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: NEEDLEMAN PHILIP CENTRAL INDEX KEY: 0001083221 RELATIONSHIP: OFFICER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: C/O MONSANTO CO STREET 2: 800 NORTH LINDBERGH BLVD CITY: ST LOUIS STATE: MO ZIP: 63167 BUSINESS PHONE: 3146941000 MAIL ADDRESS: STREET 1: C/O MONSANTO CO STREET 2: 800 NORTH LINDBERGH BLVD CITY: ST LOUIS STATE: MO ZIP: 63167 4 1 a34975.htm PHILIP NEEDLEMAN
FORM 4

[__] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).

(Print or Type Responses)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL



OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.5
1. Name and Address of Reporting Person*
   Needleman, Philip 

(Last)                      (First)                      (Middle)

  100 Route 206 North

(Street)

  Peapack, NJ 07977

(City)                      (State)                      (Zip)

2. Issuer Name and Ticker
    or Trading Symbol

   Pharmacia - PHA

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)

     
4. Statement for
    (Month/Day/Year)

   01/02/2002


5. If Amendment,
    Date of Original
    (Month/Day/Year)

    
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)


  __   Director                                __   10% Owner

   X    Officer (give title below)        __   Other (specify below)

    Senior Executive Vice President    

7. Individual or Joint/Group Filing (Check Applicable Line)

  _ X    Form filed by One Reporting Person

  ____    Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
    (Instr. 3)

2. Transaction Date
    (Month/Day/Year)
2A. Deemed Execution       Date, if any
      (Month/Day/Year)
3. Transaction Code
    (Instr. 8)
4. Securities Acquired (A) or
    Disposed of (D)
    (Instr. 3, 4, and 5)
5. Amount of
    Securities
    Beneficially
    Owned
    Following     Reported     Transaction(s)
    (Instr. 3 and 4)
6. Ownership Form:
    Direct (D) or
    Indirect (I)
    (Instr. 4)
7. Nature of Indirect Beneficial
    Ownership
    (Instr. 4)
Code V Amount (A) or (D) Price
           

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
    (Instr. 3)
2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security
3. Transaction
    Date  (Month/
    Day/ Year)
3A. Deemed
      Execution Date,
      if any (Month/
      Day/ Year)
4. Transaction Code     
    (Instr.8)

5. Number of
   
Derivative
    Securities Acquired
    (A)
    or Disposed of (D)
    (Instr. 3, 4 and 5)

6. Date Exercisable and
    Expiration Date
    (Month/Day/Year)
7. Title and Amount
    of  Underlying
    Securities
    (Instr. 3 and 4)
8. Price of
    Derivative
    Security
    (Instr. 5)
9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    Following
    Reported
    Transaction(s)
    (Instr. 4)
10. Ownership
     Form of      Derivative
     Securities:
     Direct (D)
     or
     Indirect (I)
     (Instr. 4)
11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr. 4)
Code V (A) (D) Date
Exercisable
Expiration
Date
Title Amount or
Number of
Shares
Phantom Stock Units 1 for 1 01/02/2002   A5   42,870   //(1) //(2) Common 42,870   45,977 (3) D  

Explanation of Responses:  (1) At the end of each calendar year 2002, 2003 and 2004, 1/3 of the units will be eligible for allocation based on Company performance for that year.
     
     (2) Distribution under the plan commences the calendar year following retirement, termination, death or disability, based on the provisions of the Savings+Plus deferred compensation plan.
     
     (3) Includes dividends accrued in the form of phantom stock units.


            /s/ Don W. Schmitz for Philip Needleman                     04/10/2003   
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
        See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient,
            See Instruction 6 for procedure.

-----END PRIVACY-ENHANCED MESSAGE-----